List of Excipients in API hydrocortisone 2.5%
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing hydrocortisone 2.5%
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Bryant Ranch Prepack | hydrocortisone 2.5% | 63629-2396 | CETYL ALCOHOL |
| Bryant Ranch Prepack | hydrocortisone 2.5% | 63629-2396 | CHOLESTEROL |
| Bryant Ranch Prepack | hydrocortisone 2.5% | 63629-2396 | GLYCERYL MONOSTEARATE |
| Bryant Ranch Prepack | hydrocortisone 2.5% | 63629-2396 | ISOPROPYL MYRISTATE |
| Bryant Ranch Prepack | hydrocortisone 2.5% | 63629-2396 | METHYLPARABEN |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for hydrocortisone 2.5%
Excipient focus: CETYL ALCOHOL
hydrocortisone 2.5% drug variants containing CETYL ALCOHOL
hydrocortisone 2.5% drug variants not containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CHOLESTEROL
hydrocortisone 2.5% drug variants containing CHOLESTEROL
hydrocortisone 2.5% drug variants not containing CHOLESTEROL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOSTEARATE
hydrocortisone 2.5% drug variants containing GLYCERYL MONOSTEARATE
hydrocortisone 2.5% drug variants not containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL MYRISTATE
hydrocortisone 2.5% drug variants containing ISOPROPYL MYRISTATE
hydrocortisone 2.5% drug variants not containing ISOPROPYL MYRISTATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
hydrocortisone 2.5% drug variants containing METHYLPARABEN
hydrocortisone 2.5% drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 40 STEARATE
hydrocortisone 2.5% drug variants containing POLYOXYL 40 STEARATE
hydrocortisone 2.5% drug variants not containing POLYOXYL 40 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 60
hydrocortisone 2.5% drug variants containing POLYSORBATE 60
hydrocortisone 2.5% drug variants not containing POLYSORBATE 60
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
hydrocortisone 2.5% drug variants containing PROPYLENE GLYCOL
hydrocortisone 2.5% drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
hydrocortisone 2.5% drug variants containing PROPYLPARABEN
hydrocortisone 2.5% drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBIC ACID
hydrocortisone 2.5% drug variants containing SORBIC ACID
hydrocortisone 2.5% drug variants not containing SORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITAN MONOSTEARATE
hydrocortisone 2.5% drug variants containing SORBITAN MONOSTEARATE
hydrocortisone 2.5% drug variants not containing SORBITAN MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
hydrocortisone 2.5% drug variants containing WATER
hydrocortisone 2.5% drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch